Molecular profiling can safely reduce radiation for women with endometrial cancer: Clinical trial results

Endometrial cancer is the most common gynecological cancer in highly-developed countries, most often affecting women after menopause. The majority of women are diagnosed at an early stage, when treatment outcomes are generally favorable.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup